Business Standard

Dolo 650 maker says drug part of Covid treatment, denies 'freebie' charges

In paracetamol market, Dolo's share rose to 24% from 15% pre-Covid-19

Dolo
Premium

Micro Labs said that use of Dolo 650 as first line of Covid-19 treatment was a part of the national treatment guidelines issued by the Centre and thus became the drug of choice among doctors.

Sohini Das Mumbai
Bengaluru-based Micro Labs — the makers of popular paracetamol brand Dolo — said the use of 650 mg paracetamol as first line of Covid-19 treatment was a part of the national treatment guidelines issued by the Centre and thus became the drug of choice among doctors.

Micro Labs further said there was no specific reason to promote the 650 mg variant over the 500 mg as both are covered under price control. Speaking to Business Standard, Micro Labs executive VP Jayaraj Govindaraju strongly refuted charges of spending Rs 1,000 crore on handing out freebies to doctors to promote its paracetamol
Topics : Coronavirus

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 22 2022 | 9:15 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com